Context Therapeutics Inc (CNTX)

01:55 AM

Can a trend reversal in Context Therapeutics Inc. lead to recovery2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com

01:55 AM

01:53 AM

Is Context Therapeutics Inc. showing signs of accumulationEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com

01:53 AM

Oct 08, 2025

Context Therapeutics to Showcase CT-95 Data at AACR 2025 - MSN

Oct 08, 2025

Oct 08, 2025

Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most - Yahoo Finance

Oct 08, 2025

Oct 07, 2025

Context Therapeutics Inc. (NASDAQ:CNTX) Receives $5.20 Consensus PT from Analysts - Defense World

Oct 07, 2025

Oct 06, 2025

Context Therapeutics Grants Stock Options to New Hire - MSN

Oct 06, 2025

Oct 06, 2025

Will Context Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the - GlobeNewswire

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Inc. to Present Trial Progress and Preclinical Data at SITC 2025 Annual Meeting - Quiver Quantitative

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of ... - Caledonian Record

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Inc. stock momentum explainedWeekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com

Oct 06, 2025

Oct 06, 2025

Is it too late to sell Context Therapeutics Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener

Oct 06, 2025

Oct 06, 2025

Developing predictive dashboards with Context Therapeutics Inc. dataJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com

Oct 06, 2025

Oct 04, 2025

Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 04, 2025

Oct 03, 2025

Context Therapeutics announces inducement grant under Nasdaq listing rule - MarketScreener

Oct 03, 2025

Oct 03, 2025

GlobeNewswire by Notified - The Manila Times

Oct 03, 2025

Oct 03, 2025

Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times

Oct 03, 2025

Oct 03, 2025

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 03, 2025

Oct 03, 2025

Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 03, 2025

Oct 03, 2025

30,000-Share Option: Context Therapeutics Grants New Hire Award at $0.97 Exercise Price, 10-year Term - Stock Titan

Oct 03, 2025

Oct 03, 2025

Context Therapeutics Gains 11%, Insider Trades Reap Benefit - simplywall.st

Oct 03, 2025

Oct 03, 2025

Is Context Therapeutics Inc. stock in correction or buying zoneWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com

Oct 03, 2025

Oct 02, 2025

Cantor Fitzgerald Initiates Coverage of Context Therapeutics (CNTX) with Overweight Recommendation - Nasdaq

Oct 02, 2025

Oct 02, 2025

This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Oct 02, 2025

Oct 01, 2025

How Context Therapeutics Inc. stock trades before earningsRate Cut & Reliable Breakout Forecasts - newser.com

Oct 01, 2025

Sep 30, 2025

What analysts say about Context Therapeutics Inc stockPortfolio Diversification Tips & Tap Into the Fastest-Growing Companies - earlytimes.in

Sep 30, 2025